Buformin; 1-Butylbiguanide; Buformine; Butylbiguanide; Butyldiguanide; 692-13-7; Butformin; Butylbiguanidum; Glybigid; 1-Butyldiguanide; n-Butylbiguanidine; Adebit; W 37; BIGUANIDE, 1-BUTYL-; Imidodicarbonimidic diamide, N-butyl-; Biforon; Diabrin; Panformin; Sindiatil; Andere; Buformine HCl; DBV; N-butylimidodicarbonimidic diamide; DBV hydrochloride; H 224; Imidodicarbonimidicdiamide, N-butyl-; Butyl guanylguanidine; CHEBI:3209; 692-13-7 (free base); Glybigidum; DTXSID6046420; Butylbiguanide hydrochloride; N-Butylbiguanide; W2115E9C7B; NCGC00164533-01; NCGC00164533-02; Buformine [INN-French]; Buforminum [INN-Latin]; Buformina [INN-Spanish]; DTXCID4026420; Buforminum; Buformina; Buformin [USAN:INN]; CAS-692-13-7; NSC113665; SB 103; EINECS 211-726-4; BRN 0607037; Butylbiguanid; UNII-W2115E9C7B; N1-Butylbiguanide; N,n-butylbiguanide; 1-n-butylbiguanide; 2-butyl-1-(diaminomethylene)guanidine; 2-butyl-1-(diaminomethylidene)guanidine; BUFORMIN [USAN]; Buformin (USAN/INN); BUFORMIN [INN]; BUFORMIN [MI]; BUFORMIN [MART.]; BUFORMIN [WHO-DD]; SCHEMBL27451; 4-04-00-00582 (Beilstein Handbook Reference); CHEMBL39736; SCHEMBL15762988; 1-butyl-3-carbamimidoyl-guanidine; Biguanide, 1-butyl-, hydrochloride; HY-B2099; ZINC4097425; Tox21_112164; N-Butyldicarbonimido/ic diamide/imido; STL484281; AKOS003382834; AKOS006228752; Tox21_112164_1; DB04830; N-butyl-1-carbamimidamidomethanimidamide; NCGC00186641-01; 2-butyl-1-(diaminomethylidene)-guanidine; W-37; CS-0017529; C07674; D00595; EN300-6889932; Q715104; SR-01000944701; SR-01000944701-1